MANGOCEUTICALS, INC. Files 8-K for Material Agreement

Ticker: MGRX · Form: 8-K · Filed: Dec 19, 2025 · CIK: 1938046

Mangoceuticals, INC. 8-K Filing Summary
FieldDetail
CompanyMangoceuticals, INC. (MGRX)
Form Type8-K
Filed DateDec 19, 2025
Risk Levelmedium
Pages2
Reading Time3 min
Key Dollar Amounts$0.0001, $2,500
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, 8-k-filing

TL;DR

MANGOCEUTICALS, INC. signed a big deal on 12/17/25. 8-K filed.

AI Summary

On December 17, 2025, MANGOCEUTICALS, INC. entered into a material definitive agreement. The company, incorporated in Texas with EIN 873841292, filed a Form 8-K to report this event. The filing also includes information on other events and financial statements and exhibits.

Why It Matters

This filing indicates a significant new contract or partnership for MANGOCEUTICALS, INC., which could impact its future business operations and financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, the specifics of which are not detailed in this initial 8-K filing.

Key Players & Entities

FAQ

What type of material definitive agreement did MANGOCEUTICALS, INC. enter into?

The filing states that MANGOCEUTICALS, INC. entered into a material definitive agreement on December 17, 2025, but the specific details of the agreement are not provided in this summary.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on December 17, 2025.

What is the principal executive office address for MANGOCEUTICALS, INC.?

The principal executive offices of MANGOCEUTICALS, INC. are located at 17130 N. Dallas Parkway, Suite 240, Dallas, Texas 75248.

What is the phone number for MANGOCEUTICALS, INC.?

The telephone number for MANGOCEUTICALS, INC., including area code, is (214) 242-9619.

What is the SIC code for MANGOCEUTICALS, INC.?

The Standard Industrial Classification (SIC) code for MANGOCEUTICALS, INC. is 8090, which falls under SERVICES-MISC HEALTH & ALLIED SERVICES, NEC.

Filing Stats: 744 words · 3 min read · ~2 pages · Grade level 10.8 · Accepted 2025-12-19 07:30:48

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MANGOCEUTICALS, INC. Date: December 19, 2025 By: /s/ Jacob D. Cohen Jacob D. Cohen Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing